QA: Indivior Pharmaceuticals Inc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001625297_2025_Indivior_Pharmaceuticals_Inc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001625297, Indivior Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 839,000,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 100,000,000
3 remainder_Assets 380,000,000
4 LiabilitiesCurrent 939,000,000
5 LiabilitiesNoncurrent 365,000,000
6 remainder_Liabilities 364,000,000
7 CostOfGoodsAndServicesSold 231,000,000
8 SellingGeneralAndAdministrativeExpense 618,000,000
9 ResearchAndDevelopmentExpense 108,000,000
10 remainder_Expenses 251,000,000
11 remainder_Revenues 1,188,000,000
12 remainder_NetIncome 23,000,000
13 remainder_ComprehensiveNetIncome -6,000,000
  yvar yval
0 Assets 1,319,000,000
1 Liabilities 1,668,000,000
2 Expenses 1,208,000,000
3 Revenues 1,188,000,000
4 StockholdersEquity -349,000,000
5 NetIncome 3,000,000
6 ComprehensiveNetIncome 0
7 BaseVar 2,706,000,000
8 EconomicCapitalRatiobeforeLimitedLiability -0.509
9 EconomicCapitalRatio 1.38

Edgar->Model Mapping

Feature Distribution